Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
NicOx SA
NicOx SA
Activities:
Research & Development
X
LinkedIn
Trending Articles
How advanced technologies are unlocking the future of drug manufacturing
As the drug production landscape changes, it opens the door to pursue hybrid opportunities that push the boundaries of technological advancement in the field, reports Jon...
Actylis and Novo Nordisk Pharmatech partner for the distribution of benzalkonium chloride
The two companies aim to expand the distribution of benzalkonium chloride within Europe
Upperton opens novel development and GMP manufacturing facility
The novel 50,000 sqft development and GMP manufacturing facility in Nottingham contains ten GMP manufacturing suites, quality control laboratories and formulation development...
Astellas begins construction of manufacturing site in Tralee
600 construction jobs and 100 specialised engineering, science and technology roles will be created from the project
Policy vacuum risks UK becoming a medicines supply backwater
The UK becoming a "backwater" supply marker could jeopardise £18bn of NHS savings from newly off-patented drugs during the next five years
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Research & Development
Nicox appoints Gavin Spencer as CEO
Spencer’s initial focus will be on securing financing to complete the Phase III trial of NCX 470, Denali
Recruitment
Nicox appoints Dr Tomas Navratil Head of Development
Research & Development
Lauren P. Silvernail appointed to Nicox Board of Directors
Renewal of the terms of office of Birgit Stattin Norinder and Michele Garufi
Finance
Nicox to transfer commercial operations to new company led by GHO Capital
The deal values Nicox's operations at up to €26m
Regulatory
US FDA grants priority review for Nicox's AC-170 new drug application
FDA assigns Prescription Drug User Fee Act (PDUFA) goal date of 18 October 2016
Finance
Nicox to buy Aciex Therapeutics
Part of strategy to create an international ophthalmic company built around therapeutics and diagnostics
Pharmaceutical
NicOx appoints three commercial executives in the US
In preparation for the launch of ophthalmic product AdenoPlus
Subscribe now